In the last trading session, 27.6 million Hims & Hers Health Inc (NYSE:HIMS) shares changed hands as the company’s beta touched 1.87. With the company’s per share price at $25.99 changed hands at -$2.0 or -7.15% during last session, the market valuation stood at $5.77B. HIMS’s last price was a discount, traded about -180.8% off its 52-week high of $72.98. The share price had its 52-week low at $11.20, which suggests the last value was 56.91% up since then. When we look at Hims & Hers Health Inc’s average trading volume, we note the 10-day average is 23.6 million shares, with the 3-month average coming to 23.27 million.
Analysts gave the Hims & Hers Health Inc (HIMS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.47. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 5 recommended HIMS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Hims & Hers Health Inc’s EPS for the current quarter is expected to be 0.21.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS was in red as seen at the end of in last trading. With action -10.81%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 7.49%, with the 5-day performance at -10.81% in the red. However, in the 30-day time frame, Hims & Hers Health Inc (NYSE:HIMS) is -24.43% down. Looking at the short shares, we see there were 54.73 million shares sold at short interest cover period of 1.48 days.
The consensus price target for the stock as assigned by Wall Street analysts is 25.5, meaning bulls need a downside of -1.92% from its current market value. According to analyst projections, HIMS’s forecast low is 21 with 68 as the target high. To hit the forecast high, the stock’s price needs a -161.64% plunge from its current level, while the stock would need to tank 19.2% for it to hit the projected low.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Year-over-year growth is forecast to reach 57.93% up from the last financial year.
Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 535.21M. 11 analysts are of the opinion that Hims & Hers Health Inc’s revenue for the current quarter will be 564.91M. The company’s revenue for the corresponding quarters a year ago was 278.17M and 315.65M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 92.40%. The estimates for the next quarter sales put growth at 78.97%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.22%. The 2025 estimates are for Hims & Hers Health Inc earnings to increase by 12.77%, but the outlook for the next 5-year period is at 31.05% per year.
HIMS Dividends
Hims & Hers Health Inc is expected to release its next quarterly earnings report on 2025-Feb-23.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.26% of Hims & Hers Health Inc shares while 78.84% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 88.85%. There are 78.84% institutions holding the Hims & Hers Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 7.7166% of the shares, roughly 16.47 million HIMS shares worth $332.55 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.7907% or 14.57 million shares worth $294.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Feb 28, 2025 were iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 12.19 shares estimated at $316.71 million under it, the former controlled 5.70% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.47% of the shares, roughly 5.27 shares worth around $137.01 million.
